Heart and Vascular Who should be screened? 40+ years old If you - PowerPoint PPT Presentation

Aug 18, 2022 •237 likes •314 views

Heart and Vascular Who should be screened? 40+ years old If you smoke /are around second-hand smoke If you are diabetic If you have a family history of heart disease, stroke, aneurysm If you are overweight If you have high

Heart and Vascular Who should be screened? ▪ 40+ years old ▪ If you smoke /are around second-hand smoke ▪ If you are diabetic ▪ If you have a family history of heart disease, stroke, aneurysm ▪ If you are overweight ▪ If you have high blood pressure ▪ If you have had any previous heart conditions
Cancer Who should be screened? While anyone can be at risk for Cancer below are some common risk factors • Age • Alcohol • Cancer causing substances • Chronic Inflammation • Diet • Family History • Hormones • Sunlight • Tobacco • Immunosuppression
HEART & VASCULAR AND CANCER SCREENING PERFORMED VIA ULTRASOUND 25 MINUTES PAIN-FREE INTERACTIVE EASY IMMEDIATE FEEDBACK
We’ve Got It Covered… Step 1 Employee Education Marketing Tools ▪ Pre-Screening Education ▪ Registration/Scheduling Step 2 ▪ Follow-up Online Scheduling Flexibility & Support Step 3 Abnormal Referrals Executive Summary
Executive Summary Example
My Story and Demo

Recommend

What is Peripheral Vascular Disease? Any vascular disease that isnt in the heart Areas

10/10/2015 Peripheral Vascular Disease Ganesh Muthappan, MD, FACC Disclosures I work for St. Charles Heart and Lung Center I am trying to build a practice in central Oregon I do own a small amount of St. Jude stock as part of a

676 views • 25 slides

Vascular Surgery Headline Surgical Treatments of Swedish Heart & Vascular Institute

Vascular Surgery Headline Surgical Treatments of Swedish Heart & Vascular Institute Swedish Neuroscience Institute Parkinsons Disease Retreat Program title Presenter Rocco G. Ciocca, M.D. FACS Carter S. Gerard MD Neurosurgeon

590 views • 22 slides

Vascular Institute Affiliate Network: 2018 Update Gill Heart and Vascular Institute Affiliate

Gill Heart and Vascular Institute Affiliate Network: 2018 Update Gill Heart and Vascular Institute Affiliate Network 4 Years Welcome Affiliates! New Affiliate Welcome! Welcome Special Guests! GHVI Affiliate Meeting Meeting agenda Gill

821 views • 17 slides

Pulmonary Vascular Changes in Pulmonary Vascular Changes in Heart Disease Heart Disease

Pulmonary Vascular Changes in Pulmonary Vascular Changes in Heart Disease Heart Disease Normal Circulatory Dynamics Normal Circulatory Dynamics Physiology Physiology Pulmonary Hypertension Pulmonary Hypertension Definition

714 views • 43 slides

Disclosures Threatening Ischemia NONE Michael S. Conte MD Division of Vascular and

4/16/2016 Anatomic Staging for Chronic Limb Disclosures Threatening Ischemia NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 Revascularization Strategies

226 views • 5 slides

Hypertension Ivan Anderson, MD Cardiologist Renown Institute for Heart and Vascular Health . .

. Hypertension Ivan Anderson, MD Cardiologist Renown Institute for Heart and Vascular Health . . Your first patient of today's clinic is Penny Pingleton, a 33-year- old woman who presents with a 3 day history of rhinorrhea, cough and sore

1.69k views • 66 slides

Revolutionary Monitoring Technology for Vascular Health SIMPLE | NON-INVASIVE | EFFECTIVE | LOW

Revolutionary Monitoring Technology for Vascular Health SIMPLE | NON-INVASIVE | EFFECTIVE | LOW COST The first sign of a heart disease is often a heart attack Current first line cardiovascular health diagnostics are insensitive at

538 views • 19 slides

Most Important Clinical Trials of the Past Decade in Vascular Intervention Andrew J. P. Klein,

Most Important Clinical Trials of the Past Decade in Vascular Intervention Andrew J. P. Klein, MD, FACC, FSCAI Interventional Cardiology Vascular and Endovascular Medicine Piedmont Heart Institute Atlanta, GA Disclosure Statement of

611 views • 50 slides

What Are My Treatment Options for AF? Mikhael El-Chami, MD FACC, FHRS Emory Heart and Vascular

What Are My Treatment Options for AF? Mikhael El-Chami, MD FACC, FHRS Emory Heart and Vascular Center Atrial Fibrillation (AF, Afib) Epidemiology of AF Treatment Options for AF Epidemiology Estimated 6 million people in U.S. with

691 views • 13 slides

Optimizing The Performance Of None Your Vascular Lab And Its Impact On Modern Vascular

4/7/2017 Disclosure Optimizing The Performance Of None Your Vascular Lab And Its Impact On Modern Vascular Practice Warren Gasper MD Adapted from slides by: UCSF Vascular Surgery Russell H. Samson, MD, RVT, FACS Clinical Professor of

513 views • 8 slides

Disclosures Failure? NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery

4/16/2016 What is the SOLUTION to Vein Graft Disclosures Failure? NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 Vein Graft Failure: An Unsolved Kunlin

542 views • 5 slides

Heart failure and vascular access flow What are the options? Jan Malik General University

Heart failure and vascular access flow What are the options? Jan Malik General University Hospital in Prague, CZ First Faculty of Medicine, Universitas Carolina, Prague, CZ Hemodynamic changes after AV access creation AV access creation

289 views • 25 slides

Swedish American Hospital Heart and Vascular Center Philip F Philip Frederic ederick St

Swedish American Hospital Heart and Vascular Center Philip F Philip Frederic ederick St Structur ructural al Op Option on AE Senior AE Senior Thesis Thesis 15 April 5 April 2008 2008 Presentation Outline Project Background

615 views • 36 slides

Cardiac Contractility II. In vivo assessment Tams Radovits MD, PhD associate professor Heart

Cardiac Contractility II. In vivo assessment Tams Radovits MD, PhD associate professor Heart and Vascular Center Semmelweis University Budapest 2018. Anatomy of the heart Anatomy of the heart II. Atrioventricular valve Semilunar valve

726 views • 50 slides

Disclosures Co-editor, Global Vascular Guidelines Writing Group Abbott Vascular (advisory

4/17/2018 Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care Michael S. Conte MD Professor and Chief, Division of Vascular and Endovascular Surgery Disclosures

751 views • 20 slides

Disclosure Upstream Therapy for Grant Atrial Fibrillation Zoll Jeffrey Olgin, MD Chief,

9/7/2012 Disclosure Upstream Therapy for Grant Atrial Fibrillation Zoll Jeffrey Olgin, MD Chief, Division of Cardiology Grant/Honorarium UC SF Medical Center Co-Director, Heart and Vascular Center Heart & Vascular Center

422 views • 20 slides

Modeling Cardiovascular Disease Using Canine Models Rodney A White, MD Medical Director,

Modeling Cardiovascular Disease Using Canine Models Rodney A White, MD Medical Director, Vascular Services MemorialCare Heart & Vascular Institute Long Beach Memorial Hospital Long Beach, California Vascular Surgeon, Harbor-UCLA Medical

275 views • 26 slides

THE HEART THE HEART MEDIASTINUM PERICARDIUM HEART THE HEART THE MEDIASTINUM The

THE HEART THE HEART MEDIASTINUM PERICARDIUM HEART THE HEART THE MEDIASTINUM The medias5num occupied by the mass of 2ssue between the two pulmonary cavi2es, is the central compartment of the thoracic cavity. The medias2num is an

1.11k views • 44 slides

UC UC SF SF Disclosures Vascular Assessment of the Diabetic Foot What are the best predictors

UC UC SF SF Disclosures Vascular Assessment of the Diabetic Foot What are the best predictors of wound healing? None Shant Vartanian MD Assistant Professor of Vascular Surgery UCSF Vascular Symposium April 20, 2013 VASCULAR SURGERY

114 views • 8 slides

Vascular Ultrasound Kim Kargaard Bredahl, MD, Ph.D Background Resident in vascular surgery

Vascular Ultrasound Kim Kargaard Bredahl, MD, Ph.D Background Resident in vascular surgery Vascular ultrasound on a daily basis Stenosis Flow measurement Aneurysms (size) Ph.d thesis 3D and contrast-enhanced ultrasound in

1.4k views • 119 slides

CHALLENGES IN DIALYSIS ACCESS Abbott Vascular Speaker, Abbott Vascular Niren Angle, MD, RVT,

DISCLOSURES Healthcare Professional Consultant & Trainer - CHALLENGES IN DIALYSIS ACCESS Abbott Vascular Speaker, Abbott Vascular Niren Angle, MD, RVT, FACS Vascular Surgery & Endovascular Therapy, EBCVT Lieutenant Colonel, USAF,

116 views • 10 slides

Late Pulmonary Vascular LUNG VASCULAR & AIRWAY DENSITY Outcomes of Prematurity Normal

4/20/2018 Preterm Birth May Limit Adult Lung Vascular & Airway Endowment Late Pulmonary Vascular LUNG VASCULAR & AIRWAY DENSITY Outcomes of Prematurity Normal Vascular & Airway Development and Aging Disrupted Development Leads

493 views • 8 slides

Randomized placebo-controlled trial of anacetrapib in 30,449 patients with atherosclerotic vascular

REVEAL: Randomized placebo-controlled trial of anacetrapib in 30,449 patients with atherosclerotic vascular disease Martin Landray and Louise Bowman on behalf of the HPS 3 / TIMI 55 - REVEAL Collaborative Group Funded by MSD, British Heart

475 views • 10 slides

Vascular Training Paradigms Robyn A. Macsata, M.D. Chief, Vascular Surgery Service Veterans

0/5 versus 5/2 Vascular Training Paradigms Robyn A. Macsata, M.D. Chief, Vascular Surgery Service Veterans Affairs Medical Center (VAMC) Assistant Professor of Surgery Georgetown University Hospital (GUH) Washington DC Definition Vascular

426 views • 18 slides